stella
beta
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer — Stella
Recruiting
Back to Castration-Resistant Prostate Carcinoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
University of California, San Francisco, San Francisco, California
View full record on ClinicalTrials.gov